Strategic fill-finish capacity was simultaneously secured through Novo Holdings' $16.5 billion acquisition of CDMO giant Catalent, through which Novo Nordisk gained three dedicated fill-finish manufacturing sites in Anagni, Italy, Brussels, Belgium, and Bloomington, Indiana, employing more than 3,000 people
Peripheral infusion of GLP-1 decreases food consumption and increases satiety in both normal and obese individuals, presumably by interaction with sensory neurones in the gastrointestinal tract or hepatoportal region (Trapp and Brierley 2022)
Abdel-Haq M, Ojha SK, Hamoudi W, Kumar A, Tripathi MK, Khaliulin I, et al
Switching to Extended-Release If gastrointestinal side effects are problematic with the immediate-release form, your doctor may switch you to metformin extended-release (ER)
Administer Mounjaro by subcutaneous injection, either in your stomach (abdomen), thigh, or upper arm, once a week at any time of the day